Biomarkers for Alzheimer Disease: Classical and Novel Candidates' Review

被引:73
|
作者
El Kadmiri, Nadia [1 ,2 ]
Said, Nadia [4 ]
Slassi, Ilham [2 ,3 ]
El Moutawakil, Bouchra [2 ,3 ]
Nadifi, Sellama [2 ]
机构
[1] IBN ZOHR Univ, LBVE, Polydisciplinary Fac Taroudant, BP 271, Taroudant 83000, Morocco
[2] Hassan II Univ Casablanca, Lab Med Genet & Mol Pathol, Fac Med & Pharm, BP 9154, Casablanca 9154, Morocco
[3] IBN ROCHD Univ Hosp, Dept Neurol, Casablanca, Morocco
[4] Hassan II Univ Casablanca, Pharmacol Lab, Fac Med & Pharm, BP 9154, Casablanca, Morocco
关键词
biomarkers; diagnosis; Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; CEREBROSPINAL-FLUID; CSF BIOMARKERS; FOLLOW-UP; FDG-PET; PLASMA; A-BETA-42; DEMENTIA; MARKERS;
D O I
10.1016/j.neuroscience.2017.07.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The biomarkers may be useful for predictive diagnosis of Alzheimer's disease (AD). The current challenge is to diagnose it in its preclinical phase. The combination of cerebrospinal fluid (CSF) biomarkers and imaging has been investigated extensively for a number of years. It can provide an increased diagnostic accuracy. This review discusses the contribution of classical biomarkers to predict AD and highlights novel candidates identified as potential markers for AD. We referred to the electronic databases PubMed/Medline and Web of Science to search for articles that were published until February 2016. Sixty-two records were included in qualitative synthesis. In the first section, the results show the contribution of biomarkers to predict and track AD considered as classical biomarkers. In the second section, the results highlight the involvement of novel candidates that should be considered for future evaluation in the characterization of the AD progression. Reported findings open prospect to define noninvasive biomarkers to predict AD before symptoms onset. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [21] A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
    Lee N.-C.
    Chien Y.-H.
    Hwu W.-L.
    Neurology and Therapy, 2017, 6 (Suppl 1) : 69 - 81
  • [22] Systematic Review of miRNA as Biomarkers in Alzheimer's Disease
    Swarbrick, S.
    Wragg, N.
    Ghosh, S.
    Stolzing, Alexandra
    MOLECULAR NEUROBIOLOGY, 2019, 56 (09) : 6156 - 6167
  • [23] Biomarkers of Alzheimer disease
    Growdon, JH
    ARCHIVES OF NEUROLOGY, 1999, 56 (03) : 281 - 283
  • [24] Biomarkers in Alzheimer disease
    Hock, C
    Gretener, D
    Maddalena, A
    Streffer, JR
    Papassotiropoulos, A
    Nitsch, RM
    NEUROBIOLOGY OF AGING, 2004, 25 : S13 - S13
  • [25] Biomarkers of Alzheimer Disease
    Budelier, Melissa M.
    Bateman, Randall J.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (01): : 194 - 208
  • [26] Novel Fluid Biomarkers for Brain Amyloid in Presymptomatic Alzheimer Disease
    Perrin, Richard
    Weng, Hua
    Coalier, Kelley
    Fagan, Anne
    Xiong, Chengjie
    Holtzman, David
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 588 - 588
  • [27] The "Alzheimer's disease signature": potential perspectives for novel biomarkers
    Davinelli, Sergio
    Intrieri, Mariano
    Russo, Claudio
    Di Costanzo, Alfonso
    Zella, Davide
    Bosco, Paolo
    Scapagnini, Giovanni
    IMMUNITY & AGEING, 2011, 8
  • [28] Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers
    Dorval, Veronique
    Nelson, Peter T.
    Hebert, Sebastien S.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2013, 6
  • [29] Novel diagnostic biomarkers of Alzheimer's disease in human CSF
    Simonsen, AH
    Andreasen, N
    Waldemar, G
    Pirttilä, T
    Davies, HA
    Blennow, K
    NEUROBIOLOGY OF AGING, 2004, 25 : S366 - S366
  • [30] DNA damage provides novel and powerful biomarkers of Alzheimer disease
    Katy Malpass
    Nature Reviews Neurology, 2012, 8 (4) : 178 - 178